Danimer Scientific (NYSE:DNMR) Stock Scheduled to Split on Friday, May 10th

Shares of Danimer Scientific, Inc. (NYSE:DNMR) are going to split on Friday, May 10th. The 4-3 split was announced on Friday, May 10th. The newly issued shares will be payable to shareholders after the market closes on Friday, May 10th.

Danimer Scientific Price Performance

Shares of NYSE:DNMR opened at $0.81 on Monday. Danimer Scientific has a one year low of $0.60 and a one year high of $3.56. The stock has a market cap of $91.98 million, a PE ratio of -0.53 and a beta of 1.62. The business’s fifty day moving average price is $1.10 and its two-hundred day moving average price is $1.09. The company has a debt-to-equity ratio of 1.37, a quick ratio of 5.26 and a current ratio of 6.87.

Danimer Scientific (NYSE:DNMR) last announced its earnings results on Thursday, March 28th. The company reported ($0.39) earnings per share for the quarter, meeting the consensus estimate of ($0.39). The firm had revenue of $10.95 million during the quarter, compared to the consensus estimate of $10.90 million. Danimer Scientific had a negative net margin of 333.03% and a negative return on equity of 49.01%. On average, analysts forecast that Danimer Scientific will post -0.92 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. Piper Sandler restated a “neutral” rating and issued a $1.25 price target (down previously from $3.50) on shares of Danimer Scientific in a report on Tuesday, April 9th. TD Cowen lowered their target price on shares of Danimer Scientific from $3.00 to $2.00 and set a “buy” rating for the company in a report on Thursday, April 4th.

Hedge Funds Weigh In On Danimer Scientific

Several hedge funds and other institutional investors have recently modified their holdings of DNMR. Principal Financial Group Inc. purchased a new stake in shares of Danimer Scientific in the third quarter worth about $27,000. SG Americas Securities LLC purchased a new stake in Danimer Scientific during the 4th quarter worth approximately $41,000. Levin Capital Strategies L.P. grew its position in shares of Danimer Scientific by 423.3% during the fourth quarter. Levin Capital Strategies L.P. now owns 78,500 shares of the company’s stock worth $80,000 after buying an additional 63,500 shares in the last quarter. Raymond James & Associates grew its holdings in Danimer Scientific by 10.1% during the 3rd quarter. Raymond James & Associates now owns 76,875 shares of the company’s stock worth $159,000 after acquiring an additional 7,040 shares in the last quarter. Finally, Virtu Financial LLC raised its stake in shares of Danimer Scientific by 628.5% in the 4th quarter. Virtu Financial LLC now owns 182,078 shares of the company’s stock valued at $186,000 after purchasing an additional 157,085 shares in the last quarter. 33.84% of the stock is owned by institutional investors and hedge funds.

Danimer Scientific Company Profile

Danimer Scientific, Inc, a performance polymer company, provides bioplastic replacements for traditional petroleum-based plastics in the United States, Germany, Poland, Belgium, Austria, and internationally. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative under the Nodax brand name for applications in films, straws, cutlery, food containers, and others; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.